LEAD PLAINTIFF DEADLINE: Johnson Fistel, LLP Encourages Investors to Contact the Firm

 
 

Johnson Fistel LLP, announces that class action lawsuits have commenced on behalf of shareholders of the publicly traded companies listed below. The Private Securities Litigation Reform Act of 1995 permits any investor who purchased common stock during the Class Period to seek appointment as lead plaintiff. A lead plaintiff acts on behalf of all other class members in directing the litigation.  The lead plaintiff can select a law firm of its choice.  An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.  If you wish to serve as lead plaintiff, you must move the Court no later than the dates listed below. If you want to discuss this action or have any questions concerning this notice, please contact lead analyst Jim Baker ( jimb@johnsonfistel.com ) at 619-814-4471. If emailing, please include a phone number.

 

Additionally, you can   Click Here   or any of the links below. There is no cost or obligation to you.

 
 
                                                                  
 

  Company Name  

 
 

   Stock Ticker   

 
 

   Join   

 
 

  Class Period
Start
 

 
 

  Class Period
End
 

 
 

  Lead Plantiff
Deadline
 

 
 

  Aquestive Therapeutics, Inc  

 
 

  (NASDAQ: AQST)  

 
 

    Click Here    

 
 

  12/2/2019  

 
 

  9/25/2020  

 
 

  4/30/2021  

 
 

  Renewable Energy Group Inc.  

 
 

  (NASDAQ: REGI)  

 
 

    Click Here    

 
 

  5/3/2018  

 
 

  2/25/2021  

 
 

  5/3/2021  

 
 

  Athenex, Inc  

 
 

  (NASDAQ: ATNX)  

 
 

    Click Here    

 
 

  8/7/2019  

 
 

  2/26/2021  

 
 

  5/3/2021  

 
 

  XL Fleet Corp  

 
 

  (NYSE: XL)  

 
 

    Click Here    

 
 

  10/2/2020  

 
 

  3/2/2021  

 
 

  5/7/2021  

 
 

  Plug Power, Inc  

 
 

  (NASDAQ: PLUG)  

 
 

    Click Here    

 
 

  11/9/2020  

 
 

  3/1/2021  

 
 

  5/7/2021  

 
 

  CytoDyn Inc.  

 
 

  (OTC: CYDY)  

 
 

    Click Here    

 
 

  3/27/2020  

 
 

  3/9/2021  

 
 

  5/17/2021  

 
 

  Lordstown Motors Corp.  

 
 

  (NASDAQ: RIDE, RIDEW)  

 
 

    Click Here    

 
 

  8/3/2020  

 
 

  3/24/2021  

 
 

  5/17/2021  

 
 

  BELLUS Health Inc.  

 
 

  (NASDAQ: BLU)  

 
 

    Click Here    

 
 

  9/5/2019  

 
 

  7/5/2020  

 
 

  5/17/2021  

 
 

  Neptune Wellness Solutions Inc.  

 
 

  (NASDAQ: NEPT)  

 
 

    Click Here    

 
 

  7/24/2019  

 
 

  2/16/2021  

 
 

  5/17/2021  

 
 

  Root, Inc.  

 
 

  (NASDAQ: ROOT)  

 
 

    Click Here    

 
 

  10/25/2020  

 
 

  3/8/2021  

 
 

  5/18/2021  

 
 
 

  About Johnson Fistel , LLP:  
Johnson Fistel , LLP is a nationally recognized shareholder rights law firm with offices in California , New York , and Georgia . The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit https://www.johnsonfistel.com . Attorney advertising. Past results do not guarantee future outcomes.

 

  Contact:  
Johnson Fistel , LLP
Jim Baker , 619-814-4471
jimb@johnsonfistel.com  

 

 Cision View original content: https://www.prnewswire.com/news-releases/lead-plaintiff-deadline-johnson-fistel-llp-encourages-investors-to-contact-the-firm-301276271.html  

 

SOURCE Johnson Fistel , LLP

 
 

News Provided by PR Newswire via QuoteMedia

The Conversation (0)
BELLUS Health Inc.

BELLUS Health Inc.

BELLUS Health Inc is a clinical-stage biopharmaceutical development company advancing novel therapeutics for conditions with a high unmet medical need, including BLU-5937, P2X3 antagonist that has the potential to be a best-in-class therapeutic for chronic cough. The company operates in one business segment namely, the development of drug candidates for health solutions.

Latest Press Releases

Related News

×